WallStreetZenWallStreetZen

NYSE: ENZ
Enzo Biochem Inc Stock

$1.18+0.01 (+0.85%)
Updated Jul 16, 2024
ENZ Price
$1.18
Fair Value Price
N/A
Market Cap
$60.72M
52 Week Low
$0.99
52 Week High
$1.71
P/E
1.28x
P/B
0.88x
P/S
11.28x
PEG
0.02x
Dividend Yield
N/A
Revenue
$4.72M
Earnings
$44.73M
Gross Margin
349%
Operating Margin
918.32%
Profit Margin
947.5%
Debt to Equity
0.35
Operating Cash Flow
-$42M
Beta
0.46
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ENZ Overview

Enzo Biochem, Inc. manufactures and sells diagnostic and research products based on genetic engineering, biotechnology, and molecular biology to clinical laboratories, researchers, and physicians in the U.S. and internationally. Offerings include proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits used for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. Enzo Biochem was founded in 1976 and is headquartered in Farmingdale, NY.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ENZ scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ENZ ($1.18) is trading below its intrinsic value of $25.52, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ENZ is good value based on its earnings relative to its share price (1.28x), compared to the US market average (31.71x)
P/E vs Market Valuation
ENZ is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more ENZ due diligence checks available for Premium users.

Be the first to know about important ENZ news, forecast changes, insider trades & much more!

ENZ News

Valuation

ENZ price to earnings (PE)

For valuing profitable companies with steady earnings
Company
1.28x
Industry
39.36x
Market
31.71x
ENZ is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ENZ is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

ENZ price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.88x
Industry
4.23x
ENZ is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ENZ price to earnings growth (PEG)

For valuing profitable companies with growth potential
ENZ is good value based... subscribe to Premium to read more.
PEG Value Valuation

ENZ's financial health

Profit margin

Revenue
$8.0M
Net Income
-$3.0M
Profit Margin
-37.6%
ENZ's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ENZ's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$93.5M
Liabilities
$24.4M
Debt to equity
0.35
ENZ's short-term assets ($75.74M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ENZ's short-term assets ($75.74M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ENZ's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ENZ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.9M
Investing
-$143.0k
Financing
-$44.0k
ENZ's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ENZ vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
ENZ$60.72M+0.85%1.28x0.88x
STIM$60.00M+5.82%-2.11x2.17x
PRPH$62.58M+1.86%-2.41x1.39x
NOTV$58.70M+6.60%-0.82x0.28x
VNRX$53.50M-2.12%-1.40x-3.43x

Enzo Biochem Stock FAQ

What is Enzo Biochem's quote symbol?

(NYSE: ENZ) Enzo Biochem trades on the NYSE under the ticker symbol ENZ. Enzo Biochem stock quotes can also be displayed as NYSE: ENZ.

If you're new to stock investing, here's how to buy Enzo Biochem stock.

What is the 52 week high and low for Enzo Biochem (NYSE: ENZ)?

(NYSE: ENZ) Enzo Biochem's 52-week high was $1.71, and its 52-week low was $0.99. It is currently -30.99% from its 52-week high and 19.19% from its 52-week low.

How much is Enzo Biochem stock worth today?

(NYSE: ENZ) Enzo Biochem currently has 51,457,660 outstanding shares. With Enzo Biochem stock trading at $1.18 per share, the total value of Enzo Biochem stock (market capitalization) is $60.72M.

Enzo Biochem stock was originally listed at a price of $14.63 in Dec 31, 1997. If you had invested in Enzo Biochem stock at $14.63, your return over the last 26 years would have been -91.93%, for an annualized return of -9.23% (not including any dividends or dividend reinvestments).

How much is Enzo Biochem's stock price per share?

(NYSE: ENZ) Enzo Biochem stock price per share is $1.18 today (as of Jul 16, 2024).

What is Enzo Biochem's Market Cap?

(NYSE: ENZ) Enzo Biochem's market cap is $60.72M, as of Jul 17, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Enzo Biochem's market cap is calculated by multiplying ENZ's current stock price of $1.18 by ENZ's total outstanding shares of 51,457,660.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.